Karma Biotechnologies focuses on developing precision immunotherapy solutions for oncology, particularly targeting solid tumors. Their primary focus is on colorectal cancer, utilizing a technology designed to deliver cytokines and other biologicals specifically to tumor and metastatic sites. This approach aims to avoid systemic toxicity while activating the body's immune response against cancer.